Annual general meeting of GlaxoSmithKline Pakistan Limitedto be held on April 27, 2016

Karachi:GlaxoSmithKline Pakistan Limitedinformed Pakistan Stock Exchange that annual general meeting of the company is scheduled to be held on April 27, 2016 at Karachi.

The agenda of the meeting will be consideration of the audited financial statement of the company for the year ended December 31, 2015, approving cash dividend, appointing and fixing the remuneration of the auditors.

Further, the closed period of the company is from April 20, 2016 to April 27, 2016 (both days inclusive).

Glaxo Smith Kline Pakistan Limited is incorporated in Pakistan as a limited liability company. The company is engaged in manufacturing and marketing of research based pharmaceutical and consumer products. The company is a subsidiary of S.R. One International B.V., Netherlands, whereas its ultimate parent company is GlaxoSmithKline Plc, UK. The stocks of the company are quoted on the Karachi and Lahore Stock Exchanges of Pakistan.

The company was created on January 1, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan Private Limited and GlaxoWellcome Pakistan Limited. Some of the pharmaceutical brands produced by the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and renowned consumer healthcare brands, which include Panadol, Horlicks, Aquafresh, Macleans and ENO.

The symbol “GLAXO” is being used by the stock exchanges for the shares of GlaxoSmithKline Pakistan Limited.